Ensure the continuous supply of all essential medicines to public health institutions.
Why this status
The objective remains unmet. In July 2025, Health Ministry officials told a parliamentary oversight committee that shortages had arisen, with only 80–90% of essential items expected to be available by year-end; this falls short of continuous supply of all essential medicines. Cabinet has since approved a 2026–2030 medicinal-drug policy to address access, quality and supply-chain challenges, but that is a response in progress rather than proof the continuity problem has been resolved.
Evidence timeline
Oldest first. Each item is labelled by whether it supports the promise being kept or cuts against it.
- 29 Jul 2025AgainstOfficial release
“At the July 2025 parliamentary oversight meeting, Ministry officials said shortages had occurred and that 80–90% of essential medicine items were expected to be available by year-end.”
Open source - 17 Aug 2026SupportsOfficial release
“Cabinet approved implementation of the National Medicinal Drug Policy 2026–2030 to ensure sustainable and equitable access to safe, quality essential medicines and address supply-chain challenges.”
Open source
Think this is wrong?
This status was assigned by an automated assessment and published without editorial review. If you are the person named, an authorised representative, or anyone who can show the record differently, tell us and we will correct it. How promise verdicts are made
Dispute this promise →